Simultaneously, GLP-1 has been demonstrated to inhibit CD36 translocation during the initial stage of DCM by triggering the GLP-1R/AKT-dependent pathway [127]. The gene discussed is GLP1R; the disease is familial dilated cardiomyopathy.